Patents Assigned to Dermatools Biotech GmbH
  • Publication number: 20100111931
    Abstract: The invention relates to the use of substances as a fundamental constituent in wound healing agents. The invention is characterized in that said substances bond to either IAP and/or integrin ?v?3 and/or thrombospondin-1 in such a way that the bond between thrombospondin-1 and IAP and/or integrin ?v?3 is inhibited.
    Type: Application
    Filed: August 28, 2009
    Publication date: May 6, 2010
    Applicant: DERMATOOLS BIOTECH GMBH
    Inventors: Mark Freyberg, Peter Friedl, Dirk Kaiser
  • Patent number: 7582725
    Abstract: The invention relates to the use of substances as a fundamental constituent in wound healing agents. The invention is characterised in that said substances bond to either IAP and/or integrin ?v?3 and/or thrombuspondin-1 in such a way that the bond between thrumbospondin-1 and IAP and/or integrin ?v?3 is inhibited.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: September 1, 2009
    Assignee: Dermatools Biotech GmbH
    Inventors: Mark Freyberg, Peter Friedl, Dirk Kaiser